| Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir R Monardo, A Mastrangelo, L Galli, A Tomelleri, V Spagnuolo, C Oltolini, ... Future Virology, 2024 | | 2024 |
| Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis … G Ponta, M Ranzenigo, A Marzi, C Oltolini, CT Din, C Uberti-Foppa, ... International Journal of Antimicrobial Agents 63 (2), 107077, 2024 | | 2024 |
| High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies G Mori, S Diotallevi, F Farina, R Lolatto, L Galli, M Chiurlo, A Acerbis, ... Microorganisms 12 (1), 117, 2024 | 1 | 2024 |
| 2408. Is Shorter Antibiotic Treatment Feasible in Patients with Cardiac Implantable Electronic Devices (CIED) Infections? Impact of Treatment Duration on 6-Month Recurrence and … G Ponta, M Ranzenigo, A Marzi, C Oltolini, CT Din, C Uberti-Foppa, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2028, 2023 | | 2023 |
| Genetic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with … FB Ciotta, F Saluzzo, A Pescò, F Di Marco, S Carletti, M Ripa, N Mancini, ... Clinical Microbiology and Infection 29 (12), 1610-1612, 2023 | | 2023 |
| Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... JAMA 330 (18), 1745-1759, 2023 | 11 | 2023 |
| High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation A Mastrangelo, R Monardo, L Galli, A Tomelleri, C Tassan Din, D Canetti, ... European Journal of Clinical Microbiology & Infectious Diseases 42 (11 …, 2023 | | 2023 |
| Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study I Margalit, G Tiseo, M Ripa, V Borghi, H Green, V Prendki, N Riccardi, ... Journal of Antimicrobial Chemotherapy 78 (6), 1505-1509, 2023 | 4 | 2023 |
| Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB D Clerici, L Galli, R Greco, AP Lugli, F Erbella, M Ripa, C Tassan Din, ... Blood Advances 7 (9), 1621-1634, 2023 | 7 | 2023 |
| Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... JAMA 329 (14), 1183-1196, 2023 | 32 | 2023 |
| Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation V Da Prat, L Galli, P Cichero, B Castiglioni, C Oltolini, C Tassan Din, ... Infectious Diseases 55 (4), 255-262, 2023 | | 2023 |
| Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) R Pascale, A Toschi, AT Aslan, G Massaro, A Maccaro, D Fabbricatore, ... International Journal of Antimicrobial Agents 61 (3), 106734, 2023 | 3 | 2023 |
| Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score G Tiseo, I Margalit, M Ripa, V Borghi, H Green, V Prendki, N Riccardi, ... Clinical Microbiology and Infection 29 (3), 379-385, 2023 | 2 | 2023 |
| Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature. G Ponta, L Bradanini, V Morena, C Mauri, M Ripa, A Castagna, F Luzzaro, ... The new Microbiologica 46 (1), 75-80, 2023 | | 2023 |
| Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield G Ponta, M Ranzenigo, A Marzi, C Oltolini, CT Din, V Spagnuolo, ... Clinical Microbiology and Infection 29 (2), 260-262, 2023 | 1 | 2023 |
| Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses GA Ramirez, M Ripa, S Burastero, G Benanti, D Bagnasco, S Nannipieri, ... Microorganisms 11 (2), 346, 2023 | 14 | 2023 |
| Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort S Nozza, AR Raccagni, R Lolatto, D Ceccarelli, L Galli, F Alberton, ... BMJ open 12 (12), e067261, 2022 | 4 | 2022 |
| Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report T Clemente, V Spagnuolo, M Bottanelli, M Ripa, B Del Forno, E Busnardo, ... Annals of Clinical Microbiology and Antimicrobials 21 (1), 1-6, 2022 | | 2022 |
| Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry M Pazdernik, B Iung, B Mutlu, F Alla, R Riezebos, W Kong, MCP Nunes, ... Infection 50 (5), 1191-1202, 2022 | 18 | 2022 |
| High risk of secondary infections following thrombotic complications in patients with COVID-19 M Ripa, L Galli, A D’Angelo, L Apruzzi, D Palumbo, C Campochiaro, ... Open forum infectious diseases 9 (9), ofac454, 2022 | 1 | 2022 |
